Manufacturing

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

Once described as “throwing processes over the wall,” tech transfer is evolving into close collaboration and communication, as potential problems are considered sooner, and new technology is applied. Joseph Szczesiul, director of technical services for UPM Pharmaceuticals, shares best practices.

Tech Transfer: Tearing Down the Wall

Rather than isolating the user in a virtual world, mixed reality allows contextualized data to be shared in real time, improving assays, standard
operating procedures, workflows, and overall tech transfer.

Mixed Reality Gains a Foothold in the Lab

Experts suggest health care providers and policymakers proceed with caution when exposing patients to the digital pill.

Smart Pills May ‘Dumb Down’ Health Care

Boehringer Ingelheim joins Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, and Imperial Innovations to form a partnership for developing a new gene therapy to treat cystic fibrosis.

Boehringer Ingelheim Licenses Global Rights to Cystic Fibrosis Gene Therapy

Real-life examples illustrate how to reduce the risks for each transferring partner and ensure that the development process meets regulatory requirements. 

How to Address Roadblocks During Technology Transfer: A CDMO’s Perspective

The National Science Foundation grant will be used to commercialize a synthetic biology platform for cancer drug development.

A-Alpha Bio Wins NSF Grant for Cancer Drug Development

Waters’ acquisition of Prosolia’s DESI technology boosts its mass spectrometry imaging portfolio.

Waters Acquires Mass Spec Technology

Nik Leist’s keynote address will explore the manufacturing of digital medicines at the CPhI North America 2018 conference in Philadelphia, PA, on Wednesday, April 25, 2018.

Keynote Address on Digital Medicines at CPhI North America 2018

Biogen will acquire an AMPA receptor potentiator for cognitive impairment associated with schizophrenia in a deal worth approximately $590 million.

Biogen to Acquire Asset for Schizophrenia Treatment from Pfizer

Honeywell offers an augmented/virtual reality approach to train the industrial workforce.